Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01958086 · ClinicalTrials.gov registry record · NA

Visuomotor Prosthetic for Paralysis

A NA study of Quadriplegia, sponsored by Richard A. Andersen, PhD.

Recruiting
Registry status
NA
Development phase
2
Enrollment target
3
Study locations

NCT01958086 is a NA study of Quadriplegia that is actively recruiting participants, run by Richard A. Andersen, PhD. The registered enrollment target is 2 participants, below the 9-participant average among 6 other Quadriplegia trials with a reported enrollment target (78% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01958086, a NA study of Quadriplegia, is actively recruiting participants, sponsored by Richard A. Andersen, PhD.

RECRUITING
Registry status
NA
Development phase
2 participants
Enrollment target
3
Study locations

Study Summary

The investigators objective is to run human clinical trials in which brain activity recorded through a "brain-chip" implanted in the human brain can be used to provide novel communication capabilities to severely paralyzed individuals by allowing direct brain-control of a computer interface. A prospective, longitudinal, single-arm early feasibility study will be used to examine the safety and effectiveness of using a neural communication system to control a simple computer interface and a tablet computer. Initial brain control training will occur in simplified computer environments, however, the ultimate objective of the clinical trial is to allow the human patient autonomous control over the Google Android tablet operating system. Tablet computers offer a balance of ease of use and functionality that should facilitate fusion with the BMI. The tablet interface could potentially allow the patient population to make a phone call, manage personal finances, watch movies, paint pictures, play videogames, program applications, and interact with a variety of "smart" devices such as televisions, kitchen appliances, and perhaps in time, devices such as robotic limbs and smart cars. Brain control of tablet computers has the potential to greatly improve the quality of life of severely paralyzed individuals. Five subjects will be enrolled, each implanted with the NCS for a period of at least 53 weeks and up to 313 weeks. The study is expected to take at least one year and up to six years in total.

Conditions Studied

Interventions

  • DEVICE Neural Communication System

Study Locations (3)

California

  • University of California Los Angeles - Los Angeles
  • California Institute of Technology - Pasadena
  • Casa Colina Centers for Rehabilitation - Pomona

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2013-10-01
Est. Completion 2031-07-31
Phase NA

Sponsor

Richard A. Andersen, PhD

3 total trials

What the Registry Record Tells You About NCT01958086

The ClinicalTrials.gov registry entry for NCT01958086 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9-participant average among 6 other Quadriplegia trials with a reported enrollment target (78% lower). The listed sponsor is Richard A. Andersen, PhD, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Quadriplegia appearing as the primary indexed condition, and to 1 intervention - of which Neural Communication System is the first listed.

NCT01958086 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01958086 about?

NCT01958086 is a clinical study titled "Visuomotor Prosthetic for Paralysis". The investigators objective is to run human clinical trials in which brain activity recorded through a "brain-chip" implanted in the human brain can be used to provide novel communication capabilities to severely paralyzed individuals by allowing direct brain-control of a computer interface. A prosp...

What is the current status of trial NCT01958086?

This trial is currently recruiting. It is a NA study. The enrollment target is 2 participants. The study started on 2013-10-01. Estimated completion is 2031-07-31.

What conditions does trial NCT01958086 study?

This clinical trial studies the following conditions: Quadriplegia.

What interventions are being tested in trial NCT01958086?

The interventions under investigation include: Neural Communication System (DEVICE).

Who is sponsoring clinical trial NCT01958086?

This trial is sponsored by Richard A. Andersen, PhD, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01958086 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quadriplegia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.